X, L., X, L., Y, L., Y, Z., J, L., & G, Z. (2021). Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study. Dove Medical Press.
Cita Chicago Style (17a ed.)X, Lin, Lin X, Li Y, Zhang Y, Lin J, y Zhang G. Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study. Dove Medical Press, 2021.
Cita MLA (8a ed.)X, Lin, et al. Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.